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Abstract
Background: In mammalian cells protein-lipid interactions at the trans-Golgi network (TGN) determine the
formation of vesicles, which transfer secretory proteins to the cellular membrane. This process is regulated by a
complex molecular network including protein kinase D (PKD), which is directly involved in the fission of transport
vesicles, and its interaction with the ceramide transfer protein CERT that transports ceramide from the endoplasmic
reticulum to the TGN.
Results: Here we present a novel quantitative kinetic model for the interactions of the key players PKD,
phosphatidylinositol 4-kinase III beta (PI4KIIIβ) and CERT at the TGN membranes. We use sampling-based Bayesian
analysis and perturbation experiments for model calibration and validation.
Conclusions: Our quantitative predictions of absolute molecular concentrations and reaction fluxes have major
biological implications: Model comparison provides evidence that PKD and CERT interact in a cooperative manner to
regulate ceramide transfer. Furthermore, we identify active PKD to be the dominant regulator of the network,
especially of CERT-mediated ceramide transfer.
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Background
All transmembrane proteins and soluble proteins that are
secreted from a cell into the extracellular space generally
pass through the endoplasmic reticulum (ER) and Golgi
complex (GC). In mammalian cells the GC constitutes a
highly ordered organelle composed of cisternal stacks, the
main function of which is the modification of proteins
and sorting to their distinct membrane localizations [1].
Cargo is received from the ER at the cis-Golgi complex,
traverses the medial Golgi stacks, then reaches the trans-
Golgi side where vesicles bud off from the trans-Golgi
network (TGN) [2,3]. The formation of these vesicles is
driven by a complex interaction of proteins and lipids and
is still only partly understood. One of the key players of
this network is protein kinase D, which comprises a family
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of three closely related serine-threonine kinases (PKD1,
PKD2 and PKD3). PKD has an established role in the regu-
lation of constitutive but also regulated vesicular transport
processes at the TGN [4].
In the following, we shortly describe the molecular
interaction network of PKD at the TGN (Figure 1 and
reviewed in [5,6]). The first TGN-localized PKD substrate
identified was PI4KIIIβ whose phosphorylation on serine
294 increased the activity of the lipid kinase, resulting in
the enhanced production of its substrate PI4P [7]. This
phosphorylated lipid is especially important in defining
Golgi membrane identity and providing a local signal-
ing platform to which several PI4P-binding proteins are
recruited, including the ceramide transfer protein CERT
[8,9].
Ceramide is produced at the ER and then transported
to the TGN in a non-vesicular manner by CERT, which
is recruited by the ER-resident membrane protein VAP
[10-12]. The mechanistic understanding is that CERT
takes up a ceramide molecule into its START domain,
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Figure 1Model of molecular interactions at the TGN, comprising the key proteins PKD, PI4KIIIβ and CERT. Chemical conversions and
changes of locations are represented by solid edges with number labels. Catalytic reactions and effective regulatory influences are represented by
dashed edges. PKD and PI4KIIIβ are present as inactive or active TGN bound forms (variables PKD, PKDpDAG, PI4KIIIβ and PI4KIIIβp, respectively).
Active TGN bound PKD activates PI4KIIIβ (R1) and detaches CERT from the TGNmembrane (R2) via phosphorylation (R3). Active PI4KIIIβ attracts CERT
to the TGN (R5) by producing PI4P (R4). Two alternatives for CERT dependent ceramide transport are depicted. (A) In model A, ceramide transfer is
ensured by a circular reaction scheme of CERT: Unphosphorylated CERT that is bound to both membranes (CERTaTGN) can deliver ceramide to the
TGN (R10). Extraction of new ceramide requires detachment from the TGN (R3) via phosphorylation (CERTpER) and subsequent dephosphorylation
(R9) at the ER (CERTaER). Thereby, PKD induced CERT phosphorylation (R2) and ceramide transfer (R10) dependent PKD activation (R8) constitute a
positive feedback mechanism (R6, R7 , R8, R2, R10), indicated by blue arrows. (B) In model B, unphosphorylated CERT (CERTa) is only transport-active
in an ER-TGN double bound state (CERTaERTGN), constantly transferring ceramide (R10). Here, CERT phosphorylation (CERTp) (R3) causes an
interruption of the transfer process and forms a negative feedback between PKD and CERT (R6, R7, R8, R2, R10), indicated by blue arrows.
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which forms a hydrophobic pocket, followed by the
release of ceramide at the TGN membrane [13]. This
transport is thought to occur at so-called membrane
contact sites (MCS) where the ER and the TGN come
into close contact [12]. At the TGN, sphingomyelin syn-
thases (SMS) catalyze the conversion of ceramide and
phosphatidylcholine (PC) to sphingomyelin (SM) and dia-
cylglycerol (DAG) [14-16]. DAG fulfills several central
functions at the TGN by activating novel PKC isoforms
which phosphorylate and activate PKD, by recruiting and
activating PKD, and by directly impacting membrane
curvature involved in the process of vesicle formation
[3,17-19]. CERT, in turn, is phosphorylated by PKD at
serine 132 [20], which serves as a priming site for mul-
tiple phosphorylations by CKIγ 2 in the serine rich (SR)
motif [21]. This hyperphosphorylation of CERT negatively
affects its affinity for PI4P and induces a conformational
change that inhibits START domain function [22]. At the
ER, CERT is dephosphorylated by PP2C [23], enhancing
the interaction of CERT with the Golgi membranes and
also with VAP [22]. Thereby, the proteins PKD, PI4KIIIβ
and CERT are involved in a complex scenario of inter-
related feedback loops [20]. Despite the knowledge on
the qualitative effects of phosphorylation on CERT mem-
brane binding and function, it is currently still unclear
how this complex molecular interaction network impacts
the efficacy of ceramide transport at ER-Golgi MCS.
Only few studies have attempted to address aspects of
TGN function by mathematical modeling. The existing
models describe mechanisms for vesicle kinetics, mem-
brane physics, and feedback in the SMS reaction [24-27].
Thus far, no quantitative model exists that describes the
kinetics of key protein interactions at the TGN impor-
tant for secretory transport. Such a quantitative dynamic
model would contribute to an increased understanding of
molecule interactions and organelle function and is there-
fore valuable to basic research. In addition, such a model
has broader relevance, as the vesicular transport from the
TGN to the plasmamembrane drives the polarizedmigra-
tion of cancer cells. A further application are biotechno-
logical interventions in the secretory pathway targeting
the optimization of the production of therapeutic proteins
in mammalian cells [28].
Here, we use mathematical modeling and perturbation
experiments to address how the feedback loops within
the PKD-CERT network interact to coordinate ceramide
transport. We present a quantitative dynamical model
for the molecular interactions at the TGN that is based
on chemical reaction kinetics. Biochemical time series
experiments after perturbation of the system and absolute
protein quantification measurements are used for model
calibration. As the information in the data is not sufficient
to identify all model parameters uniquely, we use sta-
tistical Bayesian approaches, which are computationally
demanding but particularly tailored to deal with this prob-
lem [29-31].
Our calibrated model is able to capture dynamic inter-
actions between PKD, PI4KIIIβ and CERT on an average
cellular level. Furthermore, validation experiments con-
firm that we are able to reliably predict different pertur-
bation scenarios. Our model-based analysis thus provides
insight into the regulatory network of key components
underlying ceramide transfer at ER-Golgi MCS.
Methods
Plasmids and reagents
Expression plasmids encoding Flag-tagged CERT as well
as EGFP-tagged CERT, PI4KIIIβ , and PKD2 are described
elsewhere [7,20]. The antibodies specific for PKD1
autophosphorylation at serine 910, phosphorylated serine
294 in PI4KIIIβ and phosphorylated serine 132 in CERT
have been described elsewhere [7,32,33]. Commercially
available antibodies used were as follows: anti-GFPmouse
monoclonal (Roche Diagnostics), anti-PI4KIIIβ rabbit
polyclonal (Millipore), anti-CERT rabbit polyclonal anti-
body (Bethyl Laboratories), anti-PKD2 rabbit polyclonal
antibody (Cell Signaling), anti-Flag M2 mouse mono-
clonal antibody (Sigma-Aldrich), anti-α-tubulin mouse
monoclonal antibody (Millipore). Recombinant purified
GFP and GST-PI4KIIIβ were obtained from Vector Labo-
ratories and Life technologies, respectively.
Cell culture
HEK293T cells were maintained in RPMI 1640 medium
supplemented with 10% FCS. For transient transfections,
3 · 105 HEK293T cells were seeded per well of a 6-well
plate. The next day, cells were transfected with 2 μg of
plasmid DNA using TransIT293 (Mirus Bio Corporation,
Madison, WI) according to the manufacturer’s instruc-
tions and grown for 24 hours. Treatment of cells with
kbNB142-70 (Tocris) and PDBu (Sigma-Aldrich) was at 10
μM and 1 μM, respectively.
Protein extraction of cells
Whole cell extracts were obtained by solubilizing cells in
lysis buffer (20 mM Tris pH 7.4, 150 mM NaCl, 1% Tri-
ton X-100, 1 mM EDTA, 1 mM ethylene glycol tetraacetic
acid (EGTA), plus Complete protease inhibitors and
PhosSTOP (Roche Diagnostics)). Lysates were clarified by
centrifugation at 16, 000g for 15 min.
Western blotting
Proteins were separated on a precast 4-12% Bis-Tris poly-
acrylamide gel (Life Technologies) and blotted onto nitro-
cellulose membranes (Pall, Dreieich, Germany). After
blocking with 0.5% blocking reagent (Roche Diagnostics),
filters were probed with specific antibodies. Proteins were
visualized with IRdye-coupled secondary antibodies on
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a Odyssey scanner followed by analysis with Odyssey
software (LI-COR Biosciences).
Image data quantification
Blots have been scanned with the LI-COR ODYSSEE
Infrared imaging system. Chanel gain was set to intensity
value 5, software gain was varied from 3 to 8 depend-
ing on the antibody in use. Gain information is contained
on all attached image files. The ’*.tif ’ image data was
exported with the LI-COR software. For quantification a
MATLAB 2011b script and the software’s image analysis
toolbox has been used. The script follows recent find-
ings of densitometry research [34] like individual lane
background correction and a unified sample tool geom-
etry of one third of average signal width. The image
analysis script can be supplied by the authors upon
request.
Software
All calculations are performed using MATLAB R2011b
scripts. Models are implemented using MATLAB tool-
boxes SBtoolbox2 and SBPD package [35]. The ODE
solvers embedded in the toolboxes are adopted from
the SUNDIALS suite [36]. Relative and absolute solver
accuracy has been set to 10−8. All MATLAB scripts are
available from the authors upon request.
Bayesian inference strategy
Here we give a short overview of the implemented
Bayesian inference strategy, for a more theoretical intro-
duction in ODEmodeling and Bayesian inference we refer
to Section Background in the supplementary text see
Additional file 1. We first perform several repeated min-
imizations using a bounded local minimization strategy
with uniformly sampled initial conditions to gain a set of
maximum a posteriori parameters estimates on a logarith-
mic scale. We then create a log uniform prior distribution
for the Bayesian inference centered several orders of mag-
nitude around the best found values (see Additional file 1:
Section 1.2). Three repeated runs of a customized version
of the parallel tempering MCMC algorithm presented in
[37] are performed using ten temperature levels. In each
run half a million samples are drawn from the poste-
rior distribution for all temperatures, using MCMC start-
ing values drawn from the best found parameter values
from the initial optimizations. Negative results for non-
convergence are successfully tested for all sampling runs
based on intra-inter-chain variance [38]. A representative
parameter subsample (Additional file 2) is used to gener-
ate the model predictions. Validation data has not been
used for model calibration. Bayes Factors for model com-
parisons (and their uncertainties) have been calculated for
each of the three independent runs via thermodynamic
integration [37].
Results
Data-drivenmodeling of PKD, PI4KIIIβ and CERT at the TGN
The exact mechanism by which CERT transfers ceramide
from the ER to the TGN is currently still unclear [6,10,13].
In particular, two models have been discussed (see e.g.
Figure six in [6]). The ’short distance shuttle’ model
suggests that CERT travels 10 nm or more through
the cytosol, shuttling between ER and TGN membranes
during the ceramide transfer process [11]. By contrast,
the ’neck-swinging’ model suggests that CERT is simul-
taneously bound to both membranes, while extracting
ceramide from the ER membranes via its START domain
and releasing it at the TGN membrane [2,39]. There are
several regulatory differences underlying these distinct
transport mechanisms, which we considered by building
two different models, A and B: First, PKD-mediated phos-
phorylation affects CERT transport activity differently in
both models. While it has a positive effect on CERT trans-
port activity in the shuttle model, it decreases transport
activity in the swinging neck model. Together with an
overall positive effect of CERT transport on PKD activity,
this constitutes a positive feedback loop for model A and a
negative feedback loop for model B, respectively, as illus-
trated in Figures 1A and 1B. Second, CERT is regulated in
a cyclic reaction scheme in the shuttle model, driven by
active PKD and active PI4KIIIβ. By contrast, in model B,
CERT transfer activity is switched on and off by PI4KIIIβ
and PKD, respectively.
Figure 1 shows a schematic scheme of the differences
between model A (top) and model B (bottom). Solid lines
represent conversions of molecules or changes in localiza-
tion, whereas dashed lines refer to regulatory or catalytic
influences. For the sake of simplicity, some regulations are
represented as effective direct regulations which summa-
rize several intermediate reactions.
The figure also shows molecular targets of the pertur-
bation experiments that are used for model calibration,
denoted by inputs u (ectopic expression of PI4KIIIβ (u3)
and CERT (u4)), as well as activation and inhibition of
PKD (u1 and u2, respectively). Moreover, measurable out-
puts y are relative phosphorylation states of PKD (y4),
CERT (y6) and PI4KIIIβ (y5).
In both models, active TGN-bound PKD (PKDpDAG)
phosphorylates and activates PI4KIIIβ (R1) and, by direct
phosphorylation (R2), triggers the detachment of CERT
from TGN membranes (R3). At the same time, active
PI4KIIIβ produces PI4P (R4), recruiting CERT back to the
TGN (R5). In turn, CERT mediated ceramide transfer has
an activating influence upon PKD, which comprises SMS
driven conversion of PC and ceramide into SM and DAG
(R6) and subsequent DAG-mediated recruitment (R7) and
activation (R8) of PKD.
In model A (Figure 1A), CERT is permanently asso-
ciated with the ER via interaction with VAP-A. After
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delivery of a ceramide molecule to the TGN, PKD-
mediated phosphorylation of CERT leads to dissociation
from the TGN (R3) while association with the ER remains.
Once dephosphorylated at the ER (R9), CERT can deliver
a new ceramide molecule to the TGN (R10).
In model B (Figure 1B), the PKD-mediated phospho-
rylation of CERT leads to its detachment from both the
TGN and ERmembranes (R3). Thus, only the unphospho-
rylated CERT molecule is associated with the TGN and
the ER and therefore transfer-active. Dephosphorylation
of CERT is required for MCS re-recruitment.
Based on the current state of knowledge about these
molecular interactions and on available measurements,
we used chemical reaction kinetics to build differen-
tial equation models for the two model variants, which
resulted in systems with seven state variables and 26
(model A) and 27 (model B) parameters, respectively.
Model equations and details are given in the Additional
file 1: Section 1.3 and Table S1.
Absolute measurements for model calibration
Calculation of absolute protein amounts per cell is a pre-
requisite to establish a quantitative model [40]. To do so,
we used an indirect method making use of a commer-
cially available recombinant GFP standard. Decreasing
numbers of recombinant GFP molecules were detected
by Western Blot analysis using a GFP-specific antibody
(Figure 2A, top). The band intensity was quantified to
generate a standard curve connecting signal strength
and protein amount (Figure 2A, bottom). Next, we tran-
siently transfected HEK293T cells with a plasmid encod-
ing GFP-tagged PI4KIIIβ . Cells were lysed 24 hours later
and expression of GFP-tagged PI4KIIIβ was detected
by quantitative Western Blot analysis using the GFP-
specific antibody. In parallel, cell lysates were probed
with a PI4KIIIβ-specific antibody, detecting endogenous
and ectopically expressed PI4KIIIβ at the same time
(Figure 2B, top). Based on the GFP signal, we deter-
mined the amount of GFP-PI4KIIIβ expressed in a defined
number of cells by inverse regression using the GFP stan-
dard curve (for details see Section 2 in the Additional
file 1). Subsequently, we calculated the absolute amount of
endogenous PI4KIIIβ , which accounted to approximately
two million molecules per cell (Figure 2C) by determin-
ing the signal ratio between endogenous and ectopically
expressed protein from Figure 2B. We then validated this
result with a commercially available purified recombi-
nant GST-PI4KIIIβ protein. Similarly to the GFP stan-
dard, we detected decreasing amounts of GST-PI4KIIIβ
by Western Blot analysis using a PI4KIIIβ-specific anti-
body (Figure 2B, bottom) and correlated the signal inten-
sity with the number of molecules. Indeed, the results
were in the same order of magnitude and in good agree-
ment with respect to the error estimates of both methods
thus confirming our calculation (Figure 2C). Likewise,
we calculated the amount of endogenous and ectopically
expressed PKD and CERT and integrated these absolute
estimates together with the estimated standard deviation
into our dataset. Our results show that a single cell con-
tains roughly half a million PKD and CERT molecules
each. The numbers of the ectopically expressed proteins
ranged from ten (GFP-tagged PKD1) to hundred million
(GFP-tagged CERT) molecules per cell (Figure 2C). Coef-
ficients of variation are determined to be between 25 to
40%, accurate enough to estimate the order of magnitude
of a protein.
Time series measurements for model calibration
In order to identify perturbations leading to a significant
system response, we performed experiments in which
we detected dynamic changes of the phosphorylation of
PKD and its substrates PI4KIIIβ and CERT. Since the
antibodies specific for phosphorylated CERT (pS132) and
PI4KIIIβ (pS294) are not suited for the detection of the
endogenous proteins we ectopically expressed CERT and
PI4KIIIβ while additionally perturbing endogenous PKD
activity by adding a respective activator and inhibitor
to the cell cultures. First, we ectopically expressed GFP-
tagged PI4KIIIβ in HEK293T cells for 24 hours and sub-
sequently left cells untreated or stimulated the cells with
Phorbol 12,13-dibutyrate (PDBu), a potent activator of
PKD [41], see Figure 3A. Cells were harvested at differ-
ent time points, and the level of active PKD was analyzed
using an antibody specific for autophosphorylated PKD
(pS910). In parallel, we detected the expression and the
PKD-mediated phosphorylation of GFP-PI4KIIIβ using
the GFP-specific and pS294-specific antibodies, respec-
tively. Stimulation of cells with PDBu steadily increased
PKD activity within one hour. Likewise, PKD-mediated
phosphorylation of PI4KIIIβ was strongly enhanced dur-
ing this time.
In a second experiment, we ectopically expressed Flag-
tagged CERT, see Figure 3B. After 24 hours, cells were
left untreated or treated with the selective PKD inhibitor
kb-NB142-70 [42] for the indicated time. Activation of
PKD as well as phosphorylation and expression of Flag-
CERT were analyzed using pS910-specific and pS132 and
Flag-specific antibodies, respectively. Expression of Flag-
CERT strongly increased endogenous PKD activity, as
can be seen from comparison of the ’0’-lanes in Figure 3
B. This activation, however, was decreased upon treat-
ment of cells with kb-NB142-70. The strongest reduction
in PKD activation was detected after treating cells with
kb-NB142-70 for 3 hours. Likewise, PKD-mediated basal
phosphorylation of CERT was reduced in kb-NB142-70
treated cells compared to untreated cells, see Additional
file 1: Section 3.1 and 3.2.
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Figure 2 Absolute quantification of endogenous proteins in HEK293T cells. (A) Top: Different amounts of recombinant GFP were loaded on a
polyacrylamide gel and visualized by Western blot analysis using a GFP-specific antibody. Bottom: Linear regression model analysis of the
recombinant GFP signals. (B) Top: HEK293T cells were transfected with an empty vector as a control or a plasmid encoding GFP-tagged PI4KIIIβ and
cultured for 24 h. Cells were lysed, and expression of endogenous and ectopically expressed PI4KIIIβ was detected by Western blot analysis using a
PI4KIIIβ-specific antibody. Detection of tubulin served as a loading control. Bottom: Different amounts of recombinant GST-tagged PI4KIIIβ were
loaded on a polyacrylamide gel and visualized by Western blot analysis using a PI4KIIIβ-specific antibody. (C) Comparison of absolute
quantifications via GST-PI4KIIIβ standard (blue) and GFP-standard (black).
Bayesian parameter estimation
Both datasets (Additional file 3), absolute protein amounts
and relative phosphorylation states after the perturbations
described were used for model calibration in a statistical
Bayesian framework. Therefore, we interpreted the mea-
surements as random variates that were generated by a
stochastic process, which is defined as the determinis-
tic solution of the differential equation model perturbed
by additive stochastic noise terms. The resulting stochas-
tic model allows us to define the likelihood function,
which assigns for each set of parameters θ the probabil-
ity p(y|θ) to obtain the dataset y. Especially in a Bayesian
approach parameters are interpreted as random variables
as well. Prior knowledge about these are included via prior
distributions p(θ) in the parameter space, which reflect
the state of knowledge about the parameters before hav-
ing seen the data. The objective in a Bayesian approach
is the posterior distribution p(θ |y), the conditional dis-
tribution in the parameter space after having taken the
data into account, which is according to Bayes’ Theorem
proportional to the product of the prior distribution and
the likelihood function, see Additional file 1: Section 1.1
and 1.2.
We investigated this distribution by generating sam-
ples via Markov Chain Monte Carlo sampling (Additional
file 1: Section 4 and 5). These samples were subsequently
used to estimate distributions for various quantities via
Monte Carlo integration. Figure 4 shows a comparison of
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Figure 3 Time series experiments. (A) HEK293T cells were transfected with a plasmid encoding GFP-tagged PI4KIIIβ and cultured for 24 h. Cells
were stimulated with PDBu for the indicated time points, lysed, and phosphorylation and expression of PI4KIIIβ were analyzed by Western blot
analysis using a pS294- and a GFP-specific antibody, respectively. Autophosphorylation of endogenous PKD was detected using the pS910-specific
antibody. Detection of tubulin served as a loading control. Shown is a representative experiment, n = 3. (B) HEK293T cells were transfected with a
control vector or a plasmid encoding Flag-tagged CERT and cultured for 24 h. Control cells were left untreated, whereas Flag-CERT transfected cells
were treated with the PKD selective inhibitor kbNB142-70 for the indicated time points. Afterwards cells were lysed, and phosphorylation and
expression of CERT were analyzed by Western blot analysis using a pS132- and a Flag-specific antibody, respectively. Autophosphorylation of
endogenous PKD was detected using the pS910-specific antibody. Detection of tubulin served as a loading control. Shown is a representative
experiment, n = 3.
the calibrated model A with the set of experimental data
that was used for calibration. Absolute endogenous pro-
tein amounts and respective distributions predicted by the
model are shown in Figure 4A. As can be seen, both agree
very well for all three proteins.
The data shown in Figures 4B-E correspond to
time series measurements after system perturbations.
Experimental data are represented as mean with standard
deviations, while respective model predictions represent
time-varying densities for the states of the system, which
are illustrated by different colors (density is increasing
from yellow to dark red). The maximum a posteriori esti-
mate that maximizes the posterior distribution is depicted
as solid black line. Outer lines represent the 99.5% confi-
dence intervals estimated from the sample.
The data shown in Figure 4B correspond to the pertur-
bation experiment in Figure 3A, i.e. ectopic expression of
PI4KIIIβ and subsequent activation of PKD with PDBu.
The absolute amount of PI4KIIIβ molecules per cell
were quantified as described after 24 h vector expression,
followed by time series experiments of phospho-PKD and
phospho-PI4KIIIβ within a few hours after treatment with
PDBu. The model suggests that PI4KIIIβ rapidly reaches a
new steady state after a fast increase within 24 hours. Fur-
thermore, PKD activity rapidly rises after treatment with
PDBu, followed by PI4KIIIβ . Both active kinases reach a
new steady state approximately 1-2 hours after treatment.
The model fit to the perturbation experiment in
Figure 3B, ectopic expression of CERT and subsequent
inhibition of PKD, is shown in Figure 4C. In contrast to
Figure 4B, in which PI4KIIIβ was ectopically expressed,
the model suggests that CERT still increases after 24
hours of vector expression. Inhibition of PKD causes a
rapid decrease in phospho-PKD, followed by a decrease in
phospho-CERT, which is well reflected in our model. Our
simulations suggest that this is a transient decrease due to
the continuing increase in the overall CERT amount.
Figure 4D depicts model-based refinement experi-
ments, which were particularly chosen in order to reduce
the variance in model predictions, as described in [43].
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Figure 4 Calibration of model A to experimental data. (A) Endogenous concentrations of PKD, PI4KIIIβ and CERT from the absolute
quantification experiments are depicted together with the model fit of the steady state distributions. (B)Model fit of ectopic expression of PI4KIIIβ
with subsequent activation of PKD via PDBu at 24 h. Depicted are the the rise of the overall PI4KIIIβ level and the change of PKD and PI4KIIIβ
phosphorylation after PDBu addition. (C)Model fit of ectopic expression of CERT with subsequent inhibition of PKD via kb-NB142-70 after 24 h.
Shown are the the rise of the overall CERT level and the change of PKD and CERT phosphorylation after kb-NB142-70 addition. (D) Refinement
experiments focusing on measurements of early PKD phosphorylation during ectopic expression of PI4KIIIβ and long time change in PKD
phosphorylation up to 6 hours after PDBu addition. (E) Validation experiment. PI4KIIIβ phosphorylation was measured at 25.25 h after ectopic
expression of PI4KIIIβ and inhibition of PKD via kb-NB142-70 at 24 h. Data were not used for model calibration.
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These are PKD activation early after ectopic expression
of PI4KIIIβ , and the long-term behavior of PKD 30 hours
after treatment with PDBu.
Overall, Figure 4 shows a very good agreement of exper-
iments and predictions of model A for all scenarios. The
figure also shows that the model uncertainty is signifi-
cantly reduced for time points near experimental data.
Moreover, while some uncertainty remains for variables
and time points far away frommeasurement instances, the
flexibility of the model was significantly reduced by the
data, which led us conclude that the model is not too com-
plex and the data contain considerable information about
model parameters.
The respective figures for model B are shown in
Additional file 1: Figure S6 and Section 6.2. The data
fit of model B shows two major differences. First, model
B is not able to reproduce the experimentally observed
early increase of PKD activity (Additional file 1: Figure
S6D, in comparison to Figure 4). Second, model B sug-
gests an overshoot of phosphorylated CERT at the begin-
ning of the ectopic expression of CERT in Additional
file 1: Figure S6C, which was not the case for model A
(Figure 4C).
In addition to this visual inspection, we decided to
use the Bayesian framework for a sophisticated model
comparison that also takes differences in model complex-
ity into account. For this purpose we used thermody-
namic integration to calculate the marginal likelihoods of
both models, which indicates the expected likelihood to
observe the data, averaged over all possible parameteriza-
tions. Then we used the Bayes factor KA,B, which is the
ratio of these two probabilities, to rank the two model
variants. The logarithmic Bayes factor reads 2 logKA,B =
12.3 ± 0.4, with standard deviation that was estimated
from three repeated sampling runs. Hence, this analysis
renders model A superior to model B with very strong evi-
dence, as described in [44] (see Additional file 1: Sections
4.3, 5 and 6.1).
Summarizing these results, our model study favors
model A, in which CERT and PKD regulate CERT trans-
port activity in a cooperative manner. Thus, we decided
to focus primarily on the analysis of model A in the
following.
Finally, Figure 4E shows an independent validation
experiment that was not used for parameter estimation
but conducted after themodel was used for a prediction of
this scenario. Here, PKD activity was inhibited 24 h after
ectopically expressing PI4KIIIβ and phospho-PI4KIIIβ
was measured 60 min after inhibition (see Additional
file 1: Figure S1B). It can be seen that also in this sce-
nario model prediction and experiment are in very good
agreement. Thus, our model not only reproduces a set of
different experiments, but can also be used for reliable
predictions of new perturbation scenarios.
Hence we are equipped with an appropriate model that
captures absolute protein levels and dynamic responses of
the system to different perturbations.
The endogenous TGN: highly responsive regulatory
couplings
We next use model A to predict and analyze the net-
work in the endogenous state. Therefore, we simulated the
system without any perturbations by setting all inputs to
zero. The system reaches a dynamic equilibrium in which
concentrations and fluxes are constant and ceramide is
constantly extracted from the ER and released to the TGN
membrane.We calculated distributions for the concentra-
tion of each molecular species, as well as distributions for
fluxes and regulatory influences in the network. The result
is illustrated in Figure 5. Expectation values for molecule
numbers per cell and fluxes in molecules per hour are
visualized by different colors on a logarithmic scale. Addi-
tionally, distributions for concentrations are shown next
to each node along with expectation values and 99.5%
confidence intervals.
In accordance with the experimental absolute quan-
tification experiments (Figure 2), PI4KIIIβ is the most
abundant protein with about 1 mio molecules per cell,
while PKD and CERT are both present with about
half a million molecules. Furthermore, most PKD and
PI4KIIIβ molecules are present in their inactive non-
phosphorylated state, while there remains large uncer-
tainty for the active states.
Flux rates correlate positively with respective protein
abundances. Accordingly, highest fluxes are encountered
for phosphorylation and dephosphorylation of PI4KIIIβ ,
followed by lower rates for PKD and CERT. Basal phos-
phorylation and dephosphorylation rates of PKD are two
orders of magnitude higher than ceramide transfer depen-
dent activation. The model also predicts that the majority
of CERT molecules is unphosphorylated. However, the
rates of phosphorylation and dephosphosphorylation are
rather similar, indicating that dephosphorylation at the ER
is very efficient. An uncertainty of several orders of mag-
nitude is predicted for TGN bound CERT (CERTaTGN),
suggesting that our data agrees with different TGN resting
times.
Regulatory influences that represent the feedback in the
network are indicated by gray lines. They have been mod-
eled with Michael Menten like kinetics that are upper
bounded with maximal rates vmax. Regulation strengths
are given in terms of these vmax values. As can be seen in
Figure 5, all regulation strengths are far below their satu-
ration values, indicating that they are highly sensitive to
changes in molecular concentrations of the regulators.
Summarizing, we are equipped with a quantitative
holistic picture of endogenous TGN functioning includ-
ing also uncertainties. The overall picture suggests that
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Figure 5 Prediction of the endogenous TGN. Prediction of protein amounts, fluxes and regulatory influences of the endogenous TGN. Model A is
simulated multiple times using a representative parameter sample from the posterior distribution with all experimental inputs inactive. The
simulation represents the endogenous Golgi of an average cell. Units for nodes are molecules per cell and flow rates are given in molecules per
hour. Mini diagrams next to the nodes depict the steady state distributions of the endogenous abundances with expectation values and 0.5% and
99.5% confidence intervals on a logarithmic scale. Color encoding of nodes and edges represent expectation values of abundances and flow rates.
In the case of PKD there are two activation reactions (basal and CERT dependent). Catalytic influences are represented with dashed arrows and are
modeled with Michaelis Menten similar kinetics. Expectation values of the operating points for these regulations are given in units of the respective
maximum reaction rate. Values far below vmax depict non-saturated coupling.
the system operates in a state that is highly responsive to
changes in the regulator concentrations.
Active PKD regulates CERT dependent ceramide transfer
The question arises whether this sensitivity of single
edges also results in a highly responsive overall net-
work response of the closed loop feedback system and
which of the key players determines the operating state
of the endogenous system. We therefore analyzed the
mutual influence of the phosphorylation state of PKD and
CERT transport activity. Simulation results are shown in
Figure 6. Figure 6A shows the relative change in PKD
activity in the case that ceramide transport activity of
CERT is completely switched off. It can be seen that
PKD activity is only slightly affected in this scenario,
with an expected increase of less than 1% with a rather
small variance. The model preserves PKD activity via the
basal ceramide independent phosphorylation reaction,
see Figure 5. Similarly, PKD activity shows an increase of
about only 0.1% in response to an increase in ceramide
transfer activity by 10% (Figure 6B). These results indicate
that PKD activity is only marginally influenced by CERT
transport activity and that CERT has a rather weak effect
on PKD activity. By contrast, a 10% increase in PKD activ-
ity resulted in an expected increase in CERT transport
activity of about 6% (Figure 6C), leading to the conclusion
that PKD is a good candidate to regulate CERT trans-
port activity. In summary, these results identify PKD as an
important regulator of the systems operating point, which
is in turn not much affected by CERT.
Discussion
In this study we present for the first time a quantita-
tive dynamic model describing the phosphorylation-
dependent CERT-mediated regulation of ceramide
transfer between ER and Golgi membranes. Our model
comprises the complex interrelated feedback loops of
interdependent TGN-localized protein and lipid kinases
on the activity of the lipid transfer protein CERT. For
model calibration we used statistical sampling-based
Bayesian inference techniques, which yield beside point
estimates also information about uncertainties in terms of
probability distributions. Our computational model was
able to reproduce the kinetic response of the molecular
interaction network comprising PKD, PI4KIIIβ and CERT
in terms of phosphorylation states to a set of different
perturbation experiments (Figures 3 and 4). Furthermore,
our model reliably predicted the behavior to new pertur-
bations, which were experimentally verified, validating
the predictive power of the model.
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Figure 6Model responses to perturbation of PKD and CERT-mediated ceramide transport. (A) The influence of CERT mediated ceramide
transfer on PKD activation is set to zero in themodel. Expected PKD activation drops by less than 1 percent. (B) Ceramide transfer is increased by 10 %
in the model. Expected PKD activity increases by 0.1%. (C) PKD activity is increased by 10% in the model. Expected ceramide transfer increases by 6%.
Using Bayesian model comparison techniques, we were
able to rank model variants that differ in the impact of
phosphorylation of CERT at the SR motif regarding its
ceramide transfer activity. In model A (Figure 1), which
is supported by our study, PKD-mediated phosphoryla-
tion of CERT constitutes an overall positive feedback loop
between CERT transfer activity and PKD activity. By con-
trast, in model B, this feedback has a negative effect on
CERT-mediated ceramide transfer. Our results thus sug-
gest that CERT and PKD interact in a cooperative rather
than a competitive manner to regulate ceramide trans-
fer activity. An experiment that helped to distinguish
between the two models was the ectopic expression of
PIKIIIβ , followed by the measurement of the phosphory-
lation and thus activation state of PKD (Figure 4D). Model
A was able to mimic the experimentally observed early
increase in PKD phosphorylation, which was not the case
for model B. In the latter model this is due to an immedi-
ate buffering of this positive effect by the strong negative
feedback on CERT mediated ceramide transfer via PKD
phosphorylation.
Although energy-consuming, the circular reaction
scheme has the advantage that it can rapidly respond
to changes at the level of the ER or Golgi to either
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accelerate or attenuate lipid metabolic pathways required
for vesicle formation at the TGN. Indeed, our model
predicts a high responsiveness for all regulations in
the endogenous system to changes in the regulator
concentrations.
Additionally, we predicted protein amounts and their
phosphorylation states, as well as fluxes between these
states and strengths of regulatory effects within the entire
molecular network for the endogenous system (Figure 5).
Predicted absolute protein amounts were in good agree-
ment with corresponding measurements (Figure 2). In
HEK293T cells, PI4KIIIβ is the most abundant protein
with about 1 million molecules per cell, followed by PKD,
while the average amount of CERT molecules per cell is
about one order of magnitude lower. Moreover, our model
predicts that the majority of both the PKD and PI4KIIIβ
molecules are present in an inactive unphosphorylated
state, while most CERT molecules are unphosphorylated
and thus transfer-active. Unfortunately, there is currently
limited literature about absolute protein abundances in
HEK293T pathways, making a direct comparison of our
quantification results difficult. However, a recent study of
the Wnt pathway in HEK293T cells reports an average
abundance of 1.6 · 105 copies per cell for these signaling
molecules [45]. This is in the same order of magnitude as
our average abundance of the key proteins for the endoge-
nous system, which we estimated to be 7 · 105 copies per
cell.
Our simulations furthermore suggest that PKD has
a strong regulatory effect on CERT transfer activity,
while, in turn, PKD activity is only modestly affected
by the amount of ceramide that is delivered to the
TGN via CERT, rendering PKD a key regulator of the
whole network state (Figure 6). This also suggests that
at the TGN, the DAG pool produced as a consequence
of CERT-mediated lipid transfer plays a minor role in
PKD recruitment and/or activation. Therefore, alternative
pathways, such as the hydrolysis of PI(4,5)P2 by PLCβ3
[46] or dephosphorylation of phosphatidic acid by lipid-
phosphate phosphatases [26,47] most likely provide DAG
to locally regulate PKD at the TGN membranes.
One limitation of our current model is its calibration
using data derived from ectopic expression experiments.
The predictions made for the behavior of the endogenous
system thus contain large uncertainties. However, early
PKD responses and absolute protein measurements were
obtained in minimally perturbed cells. The model is cur-
rently calibrated with data from HEK293T cells since this
cell line is well suited for experimental interventions like
transfections with expression constructs. However, mul-
tiple interactions in our model have also been identified
in other mammalian epithelial cell lines like HeLa cells,
and structural homology in the regulation of the TGN has
been observed [4,18].
An important issue in Bayesian learning approaches is
the impact of the prior distribution on the results. Since
there was limited quantitative literature data that could
directly be included into our model, we decided to work
with a rather conservative approach. We used log uni-
form prior distributions for all parameters, which cover
a wide range of orders of magnitude. Bounds were taken
from the literature whenever available, such as for exam-
ple in case of protein half lifes or protein amounts [48,49].
In addition, we took initial parameter optimization runs
into account to set sufficiently conservative estimates for
upper and lower bounds. Thus our priors are rather unin-
formative. Since the data contains quite some information
about the model, as can be seen by the model fits, we
believe that our results are not dominated by the prior dis-
tributions. However, as it is usually the case with Bayesian
inference, we are aware that the results depend on the
parametrization and thus might look different when using
uniform priors after a transformation of the parameters.
In the future, our model is not only useful to predict
perturbations at the protein level, but can also serve as
a starting point to investigate further molecular inter-
actions of interest via suitable model extensions. First,
by combining the model developed here with a previous
model describing the regulation of the SMS1 reaction at
the TGN [27], it will be possible to predict lipid synthesis
and transfer rates in vivo, which are difficult to measure
experimentally.
Second, experimental results described in [22] provide
ideas for further extensions regarding CERT transport
activity. While our model is qualitatively able to repro-
duce the observed decrease in ceramide transport of a
CERT-10E mutant, which mimics the hyperphosphory-
lated state, capturing the behavior of the S132A mutant
that cannot be phosphorylated at the SRM, would require
structural extensions. Furthermore, it was reported that
the amount of sphingomyelin in the plasma membrane
affects CERT activity via the regulation of its phospho-
rylation state, thereby constituting a negative feedback
mechanism in cellular lipid homeostasis. Interestingly,
phosphorylation at an additional site, namely serine 315,
via a still unknown kinase was recently reported to
enhance the affinity of CERT for VAP at the ER, thereby
upregulating ER to Golgi trafficking of ceramide [50]. The
post-translational modification of CERT by phosphoryla-
tion thus appears to be a central general mechanism by
which ceramide transfer at MCS is regulated.
Third, alternative metabolic pathways that contribute to
local DAG generation at the TGNmembranes can be inte-
grated into our model, enabling the study of the dynamic
behavior of PKD activation and/or recruitment [51].
Finally, it will be interesting to integrate into our
model additional proteins such as the sterol transfer pro-
tein OSBP. Similar to CERT, OSBP contains an FFAT
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motif and a PH domain which target the protein to
ER and Golgi membranes, respectively [13]. Importantly,
OSBP is also regulated by PKD-mediated phosphoryla-
tion and is thought to stabilize CERT localization at MCS,
thereby coordinating sphingomyelin synthesis with sterol
metabolism [52].
Conclusions
In sum, our computational analysis of ceramide transport
between the ER and Golgi membranes reveals the cooper-
ativity between PKD and CERT and identifies PKD as the
critical regulator in the system. Based on these findings
and its further implications, we believe that our quantita-
tive computational model constitutes a valuable contribu-
tion towards the holistic mechanistic understanding of the
molecular network supporting Golgi secretory function.
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